Principles of Transparency and
Best Practice

  • HOME
  • Best practice
  • Principles of transparency and best practice
  • Posted in September 11, 2019

Table of Contents

1. Website

  • i. The URL address of official journal web site is
  • ii. Aims & Scope
  • The aims of the journal are to publish important articles, encourage the exchange of information between members and related healthcare providers, and improve patient and public health. The journal is distributed to members, related agencies, libraries and the International Union Against Tuberculosis and Lung Disease member countries.
  • The journal publishes high-quality, peer-reviewed clinical or research articles that contribute to the understanding of the pathophysiology, diagnosis, and treatment of tuberculosis and other respiratory diseases.
  • Manuscripts that fall outside the scope of the journal may be rejected for evaluation by the editorial board.
    Article types published are Original Article, Review, Image of the Month, Editorial and Letter to the Editor. The journal is published quarterly (January, April, July, and October).
  • TRD is indexed/tracked/covered by Emerging Sources Citation Index (ESCI), KoreaMed, Synapse, KoMCI, PubMed, PubMed Central, CrossRef, SCOPUS, EMBASE, CAS, and Google Scholar.
  • iii. Readership
  • It is primarily for pulmonologists who seek the information about respiratory diseases and related science, but its readership can be expanded to other positions; Researchers have access to recent clinical respiratory research topics and detailed research methods; Clinicians in the field have access to new information and recent pulmonary and critical care developments for their patients; Medical teachers are able to access and adopt a variety of medical education data; Allied health professionals, including nurses, have access to recent information concerning the care of subjects with respiratory diseases; Medical health students can learn about recent trends in the field and read about interesting cases; Policymakers are able to reflect on the article results and apply them in nationwide healthcare policies for subjects with respiratory diseases. The public, especially subjects with respiratory diseases, are able to read about the advancements in their diseases, increasing their knowledge and inspiring confidence in the clinicians and researchers' devotion.
  • iv. Authorship criteria:
  • In accordance with the ICMJE recommendations defining the role of authors, authorship should be based on all four of the following criteria. Please see the ICMJE Recommendations( for more information.
    • 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
    • 2) Drafting the work or revising it critically for important intellectual content; AND
    • 3) Final approval of the version to be published; AND
    • 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  • v. Duplicate submission and redundant publication:
  • The submitted manuscript should be original and should not either had been published or submitted to other scientific journals at the same time. In addition, part or all of the accepted manuscript should not be duplicated in other scientific journals without the permission of the editorial committee. The submitted manuscript will be evaluated for possible plagiarism or duplicated publication by CrossCheck upon arrival. If plagiarism or duplicate publications related to the paper of this journal are detected, these issues will be announced in the journal, the institute of the authors will be informed and penalties will be imposed on the authors. It is mandatory for authors to resolve any copyright issues when citing a figure or table from other journals which are not open access.
  • With regard to all matters associated with research ethics, such as ethical guidelines and plagiarism/duplicate publication/scientific misconduct, the review and processing procedures are based on 'Good Publication Practice Guidelines for Medical Journals' ( and 'Guidelines on Good Publication' (
  • vi. pISSN: 1738-3536 eISSN: 2005-6184
  • 2. Name of Journal

    • The official journal title is Tuberculosis and Respiratory Diseases which is the official journal of the Korean Academy of Tuberculosis and Respiratory Diseases. Abbreviated title is Tuberc Respir Dis.

    3. Peer Review Process

    • A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria, The Editor-in-Chief and an Associate Editor generally review the submitted manuscripts. Then the selected manuscripts are reviewed by single-blinded peer review. Upon completion of the review, notification of acceptance or rejection will be sent to the corresponding author by e-mail. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers.
    • If a revised version is requested, it should be returned no later than 90 days after notification. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. A delayed revised article will be treated as a new manuscript.
    • Peer review process for handling submissions from editors, employees, or members of the editorial board :
      All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts although they are commissioned ones.

    4. Ownership and Management

    • Information about the ownership:
    • This journal is owned by the publisher, the Korean Academy of Tuberculosis and Respiratory Diseases (
    • Editor-in-Chief: Ki-Suck Jung, Hallym University, Republic of Korea
    • Deputy Editors:
    • Jae Hwa Cho, Yonsei University, Republic of Korea
    • Chin Kook Rhee, The Catholic University of Korea, Republic of Korea
    • Manager of the Review Process:
    • Yoon Soo Chang, Yonsei University, Seoul, Republic of Korea
    • Yong-Il Hwang, Hallym University, Republic of Korea
    • Kyeongman Jeon, Sungkyunkwan University, Republic of Korea
    • Won-Young Kim, Chung-Ang University, Republic of Korea
    • Woo Jin Kim, Kangwon National University, Republic of Korea
    • Jae Seung Lee, University of Ulsan, Republic of Korea
    • Sung Yong Lee, Korea University, Republic of Korea
    • Seoung Ju Park, Jeonbuk National University, Republic of Korea
    • Seung Won Ra, University of Ulsan, Republic of Korea
    • Jin Woo Song, University of Ulsan, Republic of Korea
    • Jae-Joon Yim, Seoul National University, Republic of Korea
    • Ethics Editor: Eun Joo Lee, Korea University, Republic of Korea
    • Statistics Editor: Seungsoo Sheen, Ajou University, Republic of Korea
    • Manuscript Editor: Young Ji Choi, Infolumi, Republic of Korea
    • Layout Editor: Soo Ho Kim, Medrang, Republic of Korea
    • Website and JATS XML File Producer: Minyoung Choi, M2PI, Republic of Korea
    • Publishing director: Hyesun Jung, The Korean Academy of Tuberculosis and Respiratory Diseases, Republic of Korea

    5. Governing Body

    • The governing body is the journal's editorial board.

    6. Editorial Team and Contact Information

    7. Copyright and Licensing

    • i. Copyright policy: All published papers become the permanent property of the Korean Academy of Tuberculosis and Respiratory Diseases. Copyrights of all published materials are owned by the Korean Academy of Tuberculosis and Respiratory Diseases. Permission must be obtained from the Korean Academy of Tuberculosis and Respiratory Diseases for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
    • ii. Licensing information: This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (
    • iii. Deposit policy: According to the deposit policy (self-archiving policy) of Sherpa/Romeo(, authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.

    8. Author Fees

    9. Process for the Identification of and Dealing with Allegations of Research Misconduct

    When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics ( The discussion and decision on the suspected cases are carried out by the Editorial Board.

    10. Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern

    We aim to ensure the integrity of the academic record of all published or potential publications. Whenever it is recognized that a significant inaccuracy, misleading statement, or distorted report has been published, it must be corrected promptly and with due prominence. If, after an appropriate investigation, an item proves to be fraudulent, it should be retracted. The retraction should be clearly identifiable to readers and indexing systems.

    Errors in published papers may be identified in the form of a corrigendum or erratum when the Editor-in-Chief considers it appropriate to inform the journal readership about a previous error and makes a correction to the error in the published article. The corrigendum or erratum will appear as a new article in the journal and will cite the original published article.

    Retractions are considered and published when there are severe errors in an article that invalidate the conclusions. Retractions are also made in cases where there is evidence of publication malpractice, such as plagiarism, duplicate publication, or unethical research. If a retraction is confirmed, the journal follows the procedure in accordance with COPE guidelines.

    Editorial expressions of concern
    Where substantial doubt arises as to the honesty or integrity of a submitted or published article, journal editors may consider issuing an expression of concern. However, expressions of concern should only be issued if an investigation into the problems relating to the article has proven inconclusive, and if there remain strong indicators that the concerns are valid. Under some rare cases, an editorial expression of concern may also be issued when an investigation is underway but a judgement will not be available for a considerable time. The expression of concern will be linked back to the published article it relates to.

    11. Publication Ethics

    Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki (, conform to the ethical guidelines specified on Uniform Requirements for Manuscripts Submitted to Biomedical Journals (, and must have been approved by an appropriate ethics committee. A statement, including the name of the ethics committee and the reference number where appropriate, must be described in the manuscript reporting such research. If a study has been granted an exemption from requiring ethics approval, this should be noted in the manuscript. Any research dealing with a clinical trial is recommended to be registered with a primary national clinical trial registration site such as, or other sites accredited by the WHO or the International Committee of Medical Journal Editors. Regarding the animal experiments, the experimental procedure must conform to the guidelines of the Institutional Ethics Board or those specified on the NIH Guide for the Care and Use of Laboratory Animals. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework and in rare cases, the Editor may contact the ethics committee for further information.

    12. Informed Consent Policy

    The Journal’s policy for informed patient consent for the submitted manuscript follows the publication ethics set out by the COPE and ICMJE recommendations. The data and information of individuals (e.g., information obtained through a doctor–patient relationship) must be handled with the highest levels of confidence and discretion. It is almost always necessary for authors to obtain written informed consent from patients. However, a report may be published without explicit consent if it meets all three of the following conditions: it is of great significance to public health (or is important in some other way); consent would be unusually difficult to obtain; and a reasonable individual would be unlikely to object to publication.

    13. Publishing Schedule

    After initial quality assurance by editorial office, 2 ~3 reviewers, who is expertise on the regarding fields, will be assigned. In the typical cases, it takes about four weeks to receive feedback from editorial office. If a revision is needed, the same process is used to review the revised manuscript. After acceptance, most articles are posted online in two to three weeks. Online First articles may be updated as they move through the production process, and therefore should not be considered final version. These articles may have additional changes from Online First publishing to final, issue-assigned version. The article title, author names and affiliations, and abstract will be provided to PubMed. TRD does not allow changes to the manuscript from the time of Online First publication until page proofs are received. Although Online First articles are indexed in PubMed, publication information will be updated as needed at the time of final publication in a numbered issue of TRD.

    14. Access

    TRD is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    15. Archiving

    It is accessible without barrier from National Library of Korea ( in the event the TRD is no longer published.

    16. Revenue Sources

    Tubuerculosis and Respiratory Diseases is a self-financed journal. It is supported neither by any agency nor government. Article publication fee and subscription charged for print issues are the only source of income. Operating expense such as the cost of maintenance of web, editing print version, pre-press preparations, and staff salaries are supported by previously mentioned resources.

    17. Advertising

    • It accepts advertisements on the following basis:
    • Eligibility of the advertised products or services
    • - All advertisements and commercially sponsored publications are independent from editorial decisions. TRD does not endorse any product or service marked as an advertisement or promoted by a sponsor in TRD publications. Editorial content is not influenced by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
    • - All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
    • - Advertising is separate from content.
    • - Content is never altered, added, or deleted to accommodate advertising.
    • - Advertisements may not be elusive or misleading and must be accurate. Advertisements should clearly identify the advertiser and the offered service or product. Overstated worded copy will not be allowed. Advertisements can be declined if they appear to be unsuitable or improper in either text or artwork.
    • - The Editor-in-Chief or Publisher reserves the right to decline or cancel any advertisement at any time.
    • - Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.
    • - Editorial decisions will not be altered by current or potential sponsors and advertisers, and will not be influenced by marketing promotion. Advertisers and sponsors have no role over the results of searches a user may perform on the website by keyword or search topic.
    • Orders
    • Any individuals or organizations who are interested in advertising their products or services in the print copies are encouraged to contact the editorial office.
      • Advertisement fee
      • For one print copy issue, the advertisement price for one whole page is 2,000,000 won, 1,500,000 won, 1,000,000 won and 700,000 won depending on the location of the printing.
        • Disclaimer
        • Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.
        • Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
        • Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.

        18. Direct marketing

        Journal propagation has been done through the journal web site Invitations to submit a review are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

Article category

Browse all articles >


Browse all articles >

Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail:                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next